Elligo Health Research

About:

Elligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.

Website: https://www.elligohealthresearch.com/

Twitter/X: ElligoHealth

Top Investors: Norwest Venture Partners, Horizon Technology Finance, Syneos Health, Piper Jaffray Merchant Banking, Excelerate Health Ventures

Description:

Elligo Health Research is a healthcare company that revolutionizes the clinical research industry with a novel approach to common trial challenges including patient participation and enrollment, and physician participation. They provide physicians and their patients the opportunity to participate in clinical trials using advanced health care informatics. Improved access to physicians and patients means sponsors reach trial enrollment goals faster, and new products are accelerated to market, benefiting patients everywhere. It brings clinical research to physician practices, accelerating the development of pharmaceutical, biotechnology, and medical device products and therapies. Elligo Health Research was founded in 2016 and is headquartered in Austin, Texas.

Total Funding Amount:

$196M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2016-01-01

Founders:

Chad Moore

Number of Employees:

251-500

Last Funding Date:

2023-10-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai